Publications by authors named "Maged Khalil"

Claim this Profile
P
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Francis P Worden, Evan Pisick, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Maged F Khalil

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Maged Khalil

J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Ajjai S Alva, Pam K Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Damien Hansra, Maged F Khalil

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature.
Rachel E Kinney, Maged Khalil

Clin Colorectal Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).
Harry H Yoon, Fang-Shu Ou, Gamini S Soori, Qian Shi, Dennis A Wigle, Maged F Khalil

Eur J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.
Robert A Huddart, Arlene O Siefker-Radtke, Arjun V Balar, Mehmet A Bilen, Thomas Powles, Maged F Khalil

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma.
Benny Johnson, Maged Khalil, Joseph Blansfield, Fan Lin, Shaobo Zhu

J Gastrointest Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature.
Maged F Khalil, Asha Thomas, Adel Aassad, Moshe Rubin, Robert N Taub

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass.
Maged Khalil, Padjama Sai, Zili He, Ashraf Aziz, William Steier

Clin Adv Hematol Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis.
Maged F Khalil, William D Wagner, Ira J Goldberg

Arterioscler Thromb Vasc Biol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis